Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionAdvisor Group, Inc.
Latest Disclosed Ownership117,270 shares
Latest Disclosed Value $ 7,629,000
Advisor Group, Inc. reports 9.90% decrease in ownership of GILD / Gilead Sciences, Inc.

On February 12, 2020 - Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 117,270 shares of Gilead Sciences, Inc. (US:GILD) valued at $7,620,205 USD as of December 31, 2019. The entity filed a previous 13F-HR on November 13, 2019 disclosing 130,150 shares of Gilead Sciences, Inc.. This represents a change in shares of -9.90% during the quarter. The current value of the position is $15,146,593 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2020-02-12 2019-12-31 13F GILEAD SCIENCES COM 375558103 117,270 -12,880 -9.90 7,629 -7.61 0.0528
2019-11-13 2019-09-30 13F GILEAD SCIENCES COM 375558103 130,150 14,340 12.38 8,257 5.41 0.0609
2019-07-31 2019-06-30 13F GILEAD SCIENCES COM 375558103 115,810 6,130 5.59 7,833 9.75 0.0601
2019-05-09 2019-03-31 13F GILEAD SCIENCES COM 375558103 109,680 -7,031 -6.02 7,137 -2.33 0.0587
2019-02-11 2018-12-31 13F GILEAD SCIENCES COM 375558103 116,711 -33,858 -22.49 7,307 -37.18 0.0717
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 150,569 24,496 19.43 11,631 30.19 0.1173
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 126,073 -14,681 -10.43 8,934 -15.84 0.1228
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 140,754 -25,297 -15.23 10,615 -10.78 0.1459
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 166,051 20,924 14.42 11,897 1.16 0.1589
2017-11-06 2017-09-30 13F GILEAD SCIENCES COM 375558103 145,127 2,362 1.65 11,760 16.37 0.1850
2017-11-03 2017-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 142,765 -7,124 -4.75 10,106 -0.76 0.1776
2017-08-11 2017-06-30 13F GILEAD SCIENCES COM 375558103 142,765 -7,124 9,953
2017-11-02 2017-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 149,889 -41,052 -21.50 10,183 -25.55 0.2057
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM 375558103 149,889 -41,052 10,057
2017-11-02 2016-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 190,941 10,683 5.93 13,677 -4.12 0.3091
2017-01-31 2016-12-31 13F GILEAD SCIENCES COM 375558103 190,941 10,683 13,500
2017-11-02 2016-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 180,258 10,827 6.39 14,265 0.96 0.3430
2016-11-08 2016-09-30 13F GILEAD SCIENCES COM 375558103 180,258 10,827 14,034
2016-08-11 2016-06-30 13F GILEAD SCIENCES COM 375558103 169,431 14,129
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.